AMICUS THERAPEUTICS INC. - COMMON STOCK
7,5350
27-августа-25 07:05:23
15 мин. задержка
Акции
+0,0150
+0,20%
Сегодняшний диапазон
7,4100 - 7,5350
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
07 янв 2024 13:00:52 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 янв 2024 04:00:00 Источник Nasdaq GlobeNewswire
-
05 дек 2023 03:00:38 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
08 ноя 2023 04:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
01 ноя 2023 04:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
27 окт 2023 04:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023
03 окт 2023 04:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
02 окт 2023 05:20:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
28 сен 2023 07:41:45 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
01 сен 2023 04:00:18 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023
29 авг 2023 04:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
21 авг 2023 04:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom
15 авг 2023 04:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
08 авг 2023 04:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Second Quarter 2023 Financial Results on August 8, 2023
31 июл 2023 04:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union
27 июн 2023 04:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces First Quarter 2023 Financial Results and Corporate Updates
10 май 2023 04:00:02 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the Bank of America 2023 Health Care Conference
02 май 2023 04:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce First Quarter 2023 Financial Results on May 10, 2023
01 май 2023 04:00:01 Источник Nasdaq GlobeNewswire
-
26 апр 2023 10:00:33 Источник Nasdaq GlobeNewswire